Navigation Links
Omeros Chosen to Present at NewsMakers in the Biotech Industry 2013 Conference
Date:9/20/2013

SEATTLE, Sept. 20, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the NewsMakers in the Biotech Industry 2013 Conference in New York City next week.  The presentation is scheduled for Friday, September 27, 2013 at 2:00 p.m. EDT.

The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page of the Company's website at www.omeros.com.  

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates, OMS302 for lens replacement surgery and OMS103HP for arthroscopy, are derived from its proprietary PharmacoSurgery® platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has six clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the pharmaceutical industry. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.

Contact:
Jennifer Cook Williams
Cook Williams Communications, Inc.
Inve
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Omeros Reports Initiation of Phase 2 Clinical Trial with OMS824
2. Omeros Reports Additional Positive Results from OMS824 Program
3. Omeros Submits OMS302 Marketing Authorization Application to European Medicines Agency
4. Omeros to Present at the Stifel Healthcare Conference 2013
5. Michael A. Jacobsen Joining Omeros as Vice President, Finance and Chief Accounting Officer
6. Omeros Corporation Reports Second Quarter 2013 Financial Results
7. Omeros to Present at the Wedbush 2013 Life Sciences Management Access Conference
8. Omeros Submits New Drug Application to U.S. FDA for OMS302
9. Omeros Reports Positive Results from OMS824 Positron Emission Tomography Clinical Trial
10. Omeros Files Clinical Trial Application for Lead Antibody in MASP-2 Program
11. Omeros Corporation Reports First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014  BioScrip ® , Inc. (NASDAQ: ... President and Chief Executive Officer, will present at the Bank of ... , , , Date: , , , Wednesday, December 3, ... p.m. EST , , , , Location: , , , ... About BioScrip, Inc. BioScrip, Inc. is ...
(Date:11/26/2014)... Zynerba Pharmaceuticals , Inc., a specialty ... synthetic cannabinoid treatments, today announced that the company will ... 2014. The conference will be held December 2 to ... New York . Zynerba,s Chairman and CEO, ... Tuesday, December 2. To listen to a ...
(Date:11/26/2014)... Nov. 26, 2014  Aridis Pharmaceuticals, Inc., a ... therapies for infectious diseases, announced today the addition ... recognized key opinion leader in the areas of ... board. Founder and Chief Executive Officer, ... Dr. Opal,s extensive experience investigating bacterial toxins and ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3
(Date:11/26/2014)... CA (PRWEB) November 26, 2014 With ... orthopedic surgeon Dr. Steven Meier has enhanced the ... offer current and prospective patients an online destination for ... really excited to present the new and improved version ... features make it easier than ever for current and ...
(Date:11/26/2014)... November 26, 2014 ISI Telemanagement ... solutions, has been award the 2014 Lync ... This award comes as a great honor to ... the Lync ecosystem. Specifically, ISI offers an integrated ... of Lync communication, including voice, video, Lync IM, ...
(Date:11/26/2014)... 2014 For those with a New Year’s ... MILLS BODYPUMP™ classes at the University of Colorado Anschutz ... been looking for. The 45- 60 minute classes have just ... Wellness Center fitness club memberships. , LES MILLS BODYPUMP™ exercise ... and are aimed at fast results , By focusing ...
(Date:11/26/2014)... Youngsters who enter puberty early are at increased risk ... was linked with a number of factors associated with ... according to the researchers. Early puberty was also linked ... peers, and having friends who were prone to getting ... found an association between early puberty and these factors, ...
(Date:11/26/2014)... Steven Reinberg HealthDay Reporter ... rules announced Tuesday by the U.S. Food and Drug Administration ... menus, and the rules even apply to movie theater popcorn ... third of their calories away from home, often consuming less ... Dr. Margaret Hamburg said during a Monday afternoon news conference. ...
Breaking Medicine News(10 mins):Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 3
... be necessary to look for tumors directly in patients with ... option, according to study results published in Cancer Research ... "A biopsy needle does not need to hit ... researcher Dan Mercola, M.D., Ph.D., professor of pathology and laboratory ...
... continue its vital research into the health and well-being of ... Bristol. The project, which recruited over 14,000 pregnant women ... the women and their children (now young adults themselves) ever ... the Medical Research Council and the University of Bristol, the ...
... been discovered by researchers at Seoul National University. It was ... expressed in lung cancer cells and also that patients demonstrating ... is published on March 31 in the open-access journal ... the world,s most common cancers and a leading cause of ...
... Reinberg HealthDay Reporter , THURSDAY, March 31 (HealthDay News) ... dropped by almost 1 percent a year and the rate of ... report shows. These declines, seen between 2003 and 2007, continue ... Importantly, this is the first time a drop in the ...
... 31, 2011) - Good-bye itching, watering eyes and sneezing. McMaster ... with an allergy to cats. Traditionally, frequent allergy shots ... other than getting rid of the family pet -- ... cats. Both options one difficult and costly, ...
... breast cancer strikes a young woman, what kind of stress, ... That question hasn,t been answered in the published psychological ... gathering data to change that, according to psychologist Georita M. ... study will survey up to 60 women recently diagnosed with ...
Cached Medicine News:Health News:New tool allows for an alternate method of prostate cancer diagnosis 2Health News:ALSPAC/Children of the 90s: 20 years old today 2Health News:U.S. Cancer Rates Continue to Fall 2Health News:U.S. Cancer Rates Continue to Fall 3Health News:McMaster vaccine has pet owners feline groovy 2Health News:Pilot study examines stress, anxiety and needs of young women with a unique breast cancer 2Health News:Pilot study examines stress, anxiety and needs of young women with a unique breast cancer 3
... 1064 nm Nd:YAG Base Platform ... ophthalmologists treating the anterior segment ... the elimination of secondary cataracts ... Selecta platform offers multiple upgrade ...
... The Alliance Catheter Delivery System ... and stabilization of the Aescula ... CDS has a patented coronary ... quick and easy access to ...
... system is Haemonetics latest ... of plasma and flexible ... collection of "jumbo" units ... plasma with optional saline ...
Optipress II Automated Blood Component Extractor for the standardized separation of whole blood into high purity individual components...
Medicine Products: